Search
Searching Content indexed under Patent by Foley & Lardner ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next
 
Title
Country
Organisation
Author
Date
1
Personalized Therapy Patent Falls As Patent-Ineligible
In a non-precedential opinion, the Federal Circuit held as patent-ineligible patent claims to personalized therapy to treat patients who would benefit from inhaled nitric oxide treatment
United States
12 Sep 2019
2
Automotive Markettrends | September 2019, Issue 3
Welcome to the latest edition of Foley's Automotive MarketTrends newsletter, which continues to highlight key trends in the industry. In this issue,
United States
12 Sep 2019
3
Walmart Gets A Patent For Using Crypto, Which May Be A Game Changer For Retail!
The-BlochChain.com reported that in "…early August 2019, Walmart announced it had published a patent for a methodology for using stable coins and distributed ledger technology to eliminate the need for credit cards, ...
United States
6 Sep 2019
4
Statements Of Efficacy And Safety Material Claim Limitations
In Allergan Sales, LLC v. Sandoz, Inc., (Fed. Cir. 2018-2207, Aug. 29, 2019), the Federal Circuit held that "wherein" clauses in a patent claim were limitations
United States
4 Sep 2019
5
Federal Circuit Finds Method Withholding Treatment Ineligible For Patenting
In its non-precedential decision in INO Therapeutics LLC v. Praxair Distribution Inc., the Federal Circuit agreed with the district court that method of treatment claims reciting "excluding"
United States
4 Sep 2019
6
Federal Circuit Contrives Substantially Similar Written Description Test
In contrast to its decision in Nuvo Pharmaceuticals, Inc. v. Dr. Reddy's Laboratories Inc., which seemed to impose a higher standard for satisfying the written description requirement
United States
28 Aug 2019
7
Doctrine Of Equivalents Not Barred By Claim Amendments
Recent Federal Circuit decisions demonstrate that the doctrine of equivalents is alive and well, and not always barred by claim amendments. In both Ajinomoto Co. v. ITC and Eli Lilly and Co. v. Hospira, Inc., the Federal...
United States
21 Aug 2019
8
Federal Circuit Agrees Genotyping Method Is Not Eligible For Patenting
In Genetic Veterinary Sciences, Inc. v. Laboklin GMBH & Co., the Federal Circuit upheld the district court decision that held claims directed to methods for genotyping a Labrador Retriever
United States
14 Aug 2019
9
USPTO Proposes Fee Hikes And New Fees
The USPTO has taken another major step in the fee-setting process for fee adjustments it expects to implement in January 2021, and published the proposed fees in the Federal Register.
United States
8 Aug 2019
10
Hedging Against An Uncertain Timeline For AV Market Adoption
While the automotive industry as a whole may be experiencing stagnant or declining growth, a new wave of collaboration has washed over the automotive industry in the first half of 2019.
United States
26 Jul 2019
11
Australia Holds The Line On Patent Eligibility Of Diagnostic Methods
In a decision underscoring that the U.S. stands (nearly) alone in holding most diagnostic methods to be not eligible for patenting, the Federal Court of Australia upheld Sequenom's Australian patent directed to prenatal diagnostic methods that involve detecting fetal DNA in maternal blood samples.
Australia
26 Jul 2019
12
Does The U.S. Need STRONGER Patents?
Last week Senators Chris Coons (D-Del.) and Tom Cotton (R-Ark.) and Representative Steve Stivers (R-Ohio) and Bill Foster (D-Ill.) reintroduced the STRONGER Patents Act, originally introduced in 2017.
United States
22 Jul 2019
13
Automotive Market Intelligence
The pace of innovation in the electric, autonomous, and connected vehicle space is staggering. These innovations relate to advanced sensors, radar and LiDAR,
United States
17 Jul 2019
14
Buyer Beware: Post-Facto Mergers A New Potential IPR Killer
Overturning prior PTAB precedent, the Federal Circuit has now held that post-facto business mergers that create a new RPI trigger the one-year bar date for filing IPR petitions on patents asserted in litigation...
United States
10 Jul 2019
15
Federal Circuit Agrees "Pharmaceutical Composition" May Be Toxic
The claim construction determinations in Mayne Pharma International Pty. Ltd. V. Merck Sharp & Dohme Corp. may leave stakeholders in the pharmaceutical space scratching their heads
United States
8 Jul 2019
16
The Challenges Of Patenting Autonomous Vehicle AI And Software
There are countless innovations being made for autonomous vehicle components, including for advanced sensors, radar and LiDAR, geolocation, and telecommunications.
United States
4 Jul 2019
17
Why The TERM Act Is A Misguided Solution To A Different Problem
The "Terminating the Extension of Rights Misappropriated (TERM) Act of 2019" would create a presumption that every other patent listed in the Orange Book
United States
1 Jul 2019
18
The Senate Holds Hearings On The State Of Patent Eligibility In America
Last week the Senate Judiciary Committee held two of three scheduled hearings on "The State of Patent Eligibility in America."
United States
20 Jun 2019
19
Federal Circuit Invalidates Vimovo Patents Questioning Possession Of Efficacy Under The Written Description Requirement
In Nuvo Pharmaceuticals, In. v. Dr. Reddy's Laboratories Inc., the Federal Circuit reversed the district court and found the asserted patents
United States
20 Jun 2019
20
U.S. Government Cannot Bring AIA Patent Challenges
On June 10, 2019, the U.S. Supreme Court held that the U.S. government cannot challenge the validity of a U.S. patent in any AIA review proceeding.
United States
19 Jun 2019
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next